Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321503 · ClinicalTrials.gov registry record
Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 45
- Enrollment target
NCT00321503 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 45 participants.
The verdict
NCT00321503 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
This study is a test of how well a new FDA-approved device is for diagnosing a condition known as laryngopharyngeal reflux (LPR). The device, which measures pH of the air in the upper throat, will be compared to several other methods for diagnosing laryngopharyngeal reflux.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321503
The ClinicalTrials.gov registry entry for NCT00321503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00321503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00321503 about?
NCT00321503 is a clinical study titled "Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)". This study is a test of how well a new FDA-approved device is for diagnosing a condition known as laryngopharyngeal reflux (LPR). The device, which measures pH of the air in the upper throat, will be compared to several other methods for diagnosing laryngopharyngeal reflux.
What is the current status of trial NCT00321503?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2006-05. Estimated completion is 2007-05.
Who is sponsoring clinical trial NCT00321503?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.